Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

NCT02513498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: Ixazomib Citrate
OTHER: Laboratory Biomarker Analysis
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]